N-methyl-D-aspartate-receptors (NMDARs) are ionotropic glutamate receptors that function in synaptic transmission, plasticity and cognition. Malfunction of NMDARs has been implicated in a variety of nervous system disorders, making them attractive therapeutic targets. Overexpression of functional NMDAR in non-neuronal cells results in cell death by excitotoxicity, hindering the development of cell-based assays for NMDAR drug discovery. Here we report a plate-based, high-throughput approach to study NMDAR function. Our assay enables the functional study of NMDARs with different subunit composition after activation by glycine/D-serine or glutamate and hence presents the first plate-based, high throughput assay that allows for the measurement of NMDAR function in glycine/D-serine and/or glutamate sensitive modes. This allows to investigate the effect of small molecule modulators on the activation of NMDARs at different concentrations or combinations of the co-ligands. The reported assay system faithfully replicates the pharmacology of the receptor in response to known agonists, antagonists, positive and negative allosteric modulators, as well as the receptor’s sensitivity to magnesium and zinc. We believe that the ability to study the biology of NMDARs rapidly and in large scale screens will enable the identification of novel therapeutics whose discovery has otherwise been hindered by the limitations of existing cell based approaches.

No abstract

Histone deacetylase 2 (HDAC2) is a major HDAC protein in the adult brain and has been shown to regulate many neuronal genes. The aberrant expression of HDAC2 and subsequent dysregulation of neuronal gene expression is implicated in neurodegeneration and brain aging. Human induced pluripotent stem cell-derived neurons (hiPSC-Ns) are widely used models for studying neurodegenerative disease mechanisms, but the role of HDAC2 in hiPSC-N differentiation and maturation has not been explored. In this study, we show that levels of HDAC2 progressively decrease as hiPSCs are differentiated towards neurons. This suppression of HDAC2 inversely corresponds to an increase in neuron-specific isoforms of Endophilin-B1, a multifunctional protein involved in mitochondrial dynamics. Expression of neuron-specific isoforms of Endophilin-B1 is accompanied by concomitant expression of a neuron-specific alternative splicing factor, SRRM4. Manipulation of HDAC2 and Endophilin-B1 using lentiviral approaches shows that the knock-down of HDAC2 or the overexpression of a neuron-specific Endophilin-B1 isoform promotes mitochondrial elongation and protects against cytotoxic stress in hiPSC-Ns, while HDAC2 knock-down specifically influences genes regulating mitochondrial dynamics and synaptogenesis. Furthermore, HDAC2 knock-down promotes enhanced mitochondrial respiration and reduces levels of neurotoxic amyloid beta peptides. Collectively, our study demonstrates a role for HDAC2 in hiPSC-neuronal differentiation, highlights neuron-specific isoforms of Endophilin-B1 as a marker of differentiating hiPSC-Ns and demonstrates that HDAC2 regulates key neuronal and mitochondrial pathways in hiPSC-Ns.

Erythroblast macrophage protein is a novel protein known to mediate attachment of erythroid cells to macrophages to form erythroblastic islands in bone marrow during erythropoiesis. Emp-null macrophages are small with round morphologies, and lack cytoplasmic projections which imply immature structure. The role of Emp in macrophage development and function is not fully elucidated. Macrophages perform varied functions (e.g. homeostasis, erythropoiesis), and are implicated in numerous pathophysiological conditions such as cellular malignancy. The objective of the current study is to investigate the interaction of Emp with cytoskeletal- and cell migration-associated proteins involved in macrophage functions. A short hairpin RNA lentiviral system was use to down-regulate the expression of Emp in macrophage cells. A cell migration assay revealed that the relocation of macrophages was significantly inhibited when Emp expression was decreased. To further analyze changes in gene expression related to cell motility, PCR array was performed by down-regulating Emp expression. The results indicated that expression of mitogen-activated protein kinase 1 and thymoma viral proto-oncogene 1 were significantly higher when Emp was down-regulated. The results implicate Emp in abnormal cell motility, thus, warrants to assess its role in cancer where tumor cell motility is required for invasion and metastasis.

Background Histone deacetylase 2 (HDAC2) is a major HDAC protein in the adult brain and has been shown to regulate many neuronal genes. Aberrant expression of HDAC2 and subsequent dysregulation of neuronal gene expression has been implicated in Alzheimer’s disease (AD) and brain aging. In vitro models of AD and other neurodegenerative disorders using human induced pluripotent stem cells (hiPSCs) are being increasingly utilized and have provided novel insights into disease mechanisms. However, the role of HDAC2 in living, human neurons and how its manipulation in an AD model may affect disease phenotypes has not been investigated. Method We used human induced pluripotent stem cells and lentiviral‐mediated manipulation of HDAC2 in hiPSC‐derived neurons to study the effects of increasing or decreasing HDAC2 expression on neuronal mitochondrial gene expression, morphology, and AD phenotypes. Result In this study, we show that levels of HDAC2 naturally decrease as hiPSCs are differentiated towards a neuronal lineage and that this suppression of HDAC2 inversely corresponds to an increase in neuronal‐specific isoforms of Endophilin‐B1, a multifunctional protein involved in mitochondrial dynamics. Manipulation of HDAC2 and Endophilin‐B1 using lentiviral approaches shows that knock‐down of HDAC2 or overexpression of Endophilin‐B1 promote mitochondrial elongation in hiPSC‐derived neurons, but HDAC2 knock‐down specifically influences genes regulating neuronal mitochondrial dynamics. We also observe that the endogenous decrease in HDAC2 levels upon neuronal differentiation also correlates with natural increases in neuronal activity and knock‐down of HDAC2 in differentiated neurons increases expression of genes related to neuronal synapses and further increases neuronal firing. Finally, we demonstrate that knock‐down of HDAC2 reduces amyloid beta peptides and the phospho/total Tau ratio in iPSC‐derived neurons. Conclusion Collectively, our study demonstrates that HDAC2 regulates key neuronal functional and bioenergetic pathways in hiPSC‐derived neurons and suggests that HDAC2 may represent a novel therapeutic target for AD.